Investigating unusual water movement
ANSTO expertise focused on understanding of reduced water levels at Thirlmere Lakes in three year collaborative project
Showing 161 - 180 of 419 results
ANSTO expertise focused on understanding of reduced water levels at Thirlmere Lakes in three year collaborative project
ANSTO has just completed the largest coordinated safety and security review of the OPAL multi-purpose research reactor, as part of a new a world-leading approach to assessing performance
A collaboration of Australian scientists has used ANSTO’s Australian Synchrotron to measure the amount of carbon that is captured in microscopic seams of deep-sea limestone, which acts as a carbon sink.
nandin is ANSTO’s Innovation Centre where science and technology entrepreneurs, startups and graduates meet industry expertise to experiment, co-create, innovate, and commercialise, creating new jobs in the high-growth industries of tomorrow.
Multi-million dollar Australian Cancer Research Foundation (ACRF) Detector launched at the Australian Synchrotron,
The 3D structure of a fungal and plant enzyme solves 50-year-old mystery.
The X-ray fluorescence microspectroscopy beamline offers a range of x-ray absorption and fluorescence spectroscopy techniques at submicron length-scales. The beamline has two microscopes optimised for complementary studies.
David Mesa is a product design engineer who has worked on many innovations and new product development projects. As a designer, he helped other companies solve their problems through design.
On average, there is now 17 per cent less rainfall across Western Australia’s south-western region than was recorded prior to 1970. This rainfall reduction has economic, social and environmental implications for the region, in particular for the growing capital of Perth, as well as water-dependent industries in the state.
The new Micro Computed Tomography (MCT) beamline is the first instrument to become operational as part of the $94 million Project BRIGHT program, which will see the completion of eight new beamlines at ANSTO’s Australian Synchrotron.
Innovative medical device Rhenium-SCT® therapy for non-melanoma skin cancer is now available in Australia